Lucas W. Buchanan - Jan 17, 2023 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
COO/CFO
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Jan 17, 2023
Transactions value $
-$4,055,490
Form type
4
Date filed
1/19/2023, 07:01 PM
Previous filing
Dec 15, 2022
Next filing
Mar 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $72K +45K +23.5% $1.60* 237K Jan 17, 2023 Direct F1
transaction SILK Common Stock Sale -$2.46M -45K -19.03% $54.68 192K Jan 17, 2023 Direct F1, F2
transaction SILK Common Stock Options Exercise $20.4K +12.8K +6.67% $1.60* 204K Jan 19, 2023 Direct F1
transaction SILK Common Stock Sale -$682K -12.8K -6.25% $53.40 192K Jan 19, 2023 Direct F1, F3
transaction SILK Common Stock Options Exercise $515K +25.8K +13.45% $20.00 217K Jan 19, 2023 Direct F1
transaction SILK Common Stock Sale -$1.38M -25.8K -11.86% $53.40 192K Jan 19, 2023 Direct F1, F3
transaction SILK Common Stock Sale -$145K -2.72K -1.42% $53.40 189K Jan 19, 2023 Direct F3, F4
holding SILK Common Stock 13.5K Jan 17, 2023 Buchanan Grandchildren's Irrevocable Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -45K -68.8% $0.00 20.4K Jan 17, 2023 Common Stock 45K $1.60 Direct F1, F6
transaction SILK Option (right to buy) Options Exercise $0 -12.8K -62.55% $0.00 7.64K Jan 19, 2023 Common Stock 12.8K $1.60 Direct F1, F6
transaction SILK Option (right to buy) Options Exercise $0 -25.8K -77.85% $0.00 7.33K Jan 19, 2023 Common Stock 25.8K $20.00 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on December 13, 2022.
F2 This transaction was executed in multiple trades at price ranging from $53.79 to $57.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at price ranging from $52.68 to $54.71. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 The sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on December 13, 2022.
F5 These shares are held directly by the Buchanan Grandchildren's Irrevocable Trust, for which the Reporting Person serves as a co-trustee.
F6 All of the shares subject to this option are fully vested and exercisable as of the date hereof.
F7 One forty-eighth of the shares subject to the option shall vest on May 3, 2019 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.